Open-house pharmaceutical discount agreements for rasagiline (ATC N04BD02)

Summary

This open-house arrangement concerns non-exclusive, identical and non-negotiable pharmaceutical discount agreements with AOK Bayern for rasagiline, active substance code ATC N04BD02. Eligible pharmaceutical companies may join during the contract period, with contracts running from 1 November 2026 to 31 October 2028. The final date for concluding a contract is 3 September 2028. Applicants must submit the completed and signed agreement, the signed schedule identifying the medicines covered by the agreement, and a signed reliability declaration. Documents may be submitted on paper with handwritten signatures or electronically with a qualified electronic signature. Complete and correct documents received by the third day of a month generally lead to a contract start on the first day of the following month. The official tender documents must be checked for the exact forms and submission instructions.